New Screening Updates

We recently reviewed and updated the surveillance recommendations for individuals who have Familial Adenomatous Polyposis (FAP), MYH-Associated Polyposis (MAP) and HNPCC/Lynch Syndrome (MLH1, MSH2, MSH6 mutations). Please contact our program to schedule an appointment to discuss these updates!